Document Detail

A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity.
MedLine Citation:
PMID:  18507748     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The objective was to investigate the use of autologous red blood cells (RBCs) derived from umbilical cord blood (UCB), as an alternative for allogeneic transfusions in premature infants admitted to a tertiary neonatal center. STUDY DESIGN AND METHODS: UCB collection was performed at deliveries of less than 32 weeks of gestation and processed into autologous RBC products. Premature infants requiring a RBC transfusion were randomly assigned to an autologous or allogeneic product. The primary endpoint was an at least 50 percent reduction in allogeneic transfusion needs. RESULTS: Fifty-seven percent of the collections harvested enough volume (> or =15 mL) for processing. After being processed, autologous products (> or =10 mL/kg) were available for 36 percent of the total study population and for 27 percent of the transfused infants and could cover 58 percent (range, 25%-100%) of the transfusion needs within the 21-day product shelf life. Availability of autologous products depended most on the gestational age. Infants born between 24 and 28 weeks had the lowest availability (17%). All products, however, would be useful in view of their high (87%) transfusion needs. Availability was highest (48%) for the infants born between 28 and 30 weeks. For 42 percent of the infants with transfusion needs in this group, autologous products were available. For the infants born between 30 and 32 weeks, autologous products were available for 36 percent of the infants. Transfusion needs in this group were, however, much lower (19%) compared to the other gestational groups. CONCLUSION: Autologous RBCs derived from UCB could not replace 50 percent of allogeneic transfusions due to the low UCB volumes collected and subsequent low product availability.
Chantal M Khodabux; Jeannette S von Lindern; Joost A van Hilten; Sicco Scherjon; Frans J Walther; Anneke Brand
Related Documents :
2758718 - Initial treatment of cystic fibrosis. frequency of transient bulging fontanel.
1567298 - Histologic pattern of testicular regrowths in caponized tom turkeys.
21470348 - Causes of stillbirth, neonatal death and early childhood death in rural zambia by verba...
99038 - Maternal-fetal hemorrhage: its incidence and sensitizing effects.
15257488 - A newly designed disposable introducer sheath for a ventricular fiberscope.
22696338 - Antifungal therapy for newborn infants with invasive fungal infection.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-05-23
Journal Detail:
Title:  Transfusion     Volume:  48     ISSN:  0041-1132     ISO Abbreviation:  Transfusion     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-20     Completed Date:  2008-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1634-43     Citation Subset:  IM    
Department of Research and Development, Sanquin Blood Bank, Southwest Division, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / blood,  therapy*
Blood Transfusion, Autologous / economics,  methods*
Blood Volume
Erythrocyte Transfusion / economics,  methods
Feasibility Studies
Fetal Blood*
Gestational Age
Health Care Costs
Infant, Newborn
Infant, Premature*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Staff attitudes about event reporting and patient safety culture in hospital transfusion services.
Next Document:  One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic...